246 related articles for article (PubMed ID: 26385518)
1. Meta-analysis comparing the effects of rosuvastatin versus atorvastatin on regression of coronary atherosclerotic plaques.
Qian C; Wei B; Ding J; Wu H; Cai X; Li B; Wang Y
Am J Cardiol; 2015 Nov; 116(10):1521-6. PubMed ID: 26385518
[TBL] [Abstract][Full Text] [Related]
2. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).
Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ
Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123
[TBL] [Abstract][Full Text] [Related]
3. Impact of Water- and Lipid-Soluble Statins on Nonculprit Lesions in Patients with Acute Coronary Syndrome.
Ishikawa Y; Itoh T; Satoh M; Fusazaki T; Sugawara S; Nakajima S; Nakamura M; Morino Y
Int Heart J; 2018 Jan; 59(1):27-34. PubMed ID: 29279527
[TBL] [Abstract][Full Text] [Related]
4. Effect of two intensive statin regimens on progression of coronary disease.
Nicholls SJ; Ballantyne CM; Barter PJ; Chapman MJ; Erbel RM; Libby P; Raichlen JS; Uno K; Borgman M; Wolski K; Nissen SE
N Engl J Med; 2011 Dec; 365(22):2078-87. PubMed ID: 22085316
[TBL] [Abstract][Full Text] [Related]
5. Is age an important factor for vascular response to statin therapy? A serial optical coherence tomography and intravascular ultrasound study.
Dai J; Hou J; Xing L; Jia H; Hu S; Soeda T; Minami Y; Ong D; Vergallo R; Zhang S; Lee H; Yu B; Jang IK
Coron Artery Dis; 2017 May; 28(3):209-217. PubMed ID: 28059849
[TBL] [Abstract][Full Text] [Related]
6. Comparison of Rosuvastatin Versus Atorvastatin for Coronary Plaque Stabilization.
Thondapu V; Kurihara O; Yonetsu T; Russo M; Kim HO; Lee H; Soeda T; Minami Y; Jang IK
Am J Cardiol; 2019 May; 123(10):1565-1571. PubMed ID: 30851941
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the Effect of Rosuvastatin 2.5 mg vs 20 mg on Coronary Plaque Determined by Angioscopy and Intravascular Ultrasound in Japanese With Stable Angina Pectoris (from the Aggressive Lipid-Lowering Treatment Approach Using Intensive Rosuvastatin for Vulnerable Coronary Artery Plaque [ALTAIR] Randomized Trial).
Takayama T; Komatsu S; Ueda Y; Fukushima S; Hiro T; Hirayama A; Saito S;
Am J Cardiol; 2016 Apr; 117(8):1206-12. PubMed ID: 26879069
[TBL] [Abstract][Full Text] [Related]
8. Effect of Statin Treatment on Modifying Plaque Composition: A Double-Blind, Randomized Study.
Park SJ; Kang SJ; Ahn JM; Chang M; Yun SC; Roh JH; Lee PH; Park HW; Yoon SH; Park DW; Lee SW; Kim YH; Lee CW; Mintz GS; Han KH; Park SW
J Am Coll Cardiol; 2016 Apr; 67(15):1772-1783. PubMed ID: 27081016
[TBL] [Abstract][Full Text] [Related]
9. Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.
Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2465-72. PubMed ID: 25212234
[TBL] [Abstract][Full Text] [Related]
10. Factors underlying regression of coronary atheroma with potent statin therapy.
Puri R; Nissen SE; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; St John J; Wolski K; Uno K; Kataoka Y; Nicholls SJ
Eur Heart J; 2013 Jun; 34(24):1818-25. PubMed ID: 23644179
[TBL] [Abstract][Full Text] [Related]
11. Lipoprotein(a) and coronary atheroma progression rates during long-term high-intensity statin therapy: Insights from SATURN.
Puri R; Ballantyne CM; Hoogeveen RC; Shao M; Barter P; Libby P; Chapman MJ; Erbel R; Arsenault BJ; Raichlen JS; Nissen SE; Nicholls SJ
Atherosclerosis; 2017 Aug; 263():137-144. PubMed ID: 28641153
[TBL] [Abstract][Full Text] [Related]
12. Comparative effects of high-dose atorvastatin versus moderate-dose rosuvastatin on lipid parameters, oxidized-LDL and inflammatory markers in ST elevation myocardial infarction.
Aydin MU; Aygul N; Altunkeser BB; Unlu A; Taner A
Atherosclerosis; 2015 Apr; 239(2):439-43. PubMed ID: 25697576
[TBL] [Abstract][Full Text] [Related]
13. Impact of baseline lipoprotein and C-reactive protein levels on coronary atheroma regression following high-intensity statin therapy.
Puri R; Nissen SE; Shao M; Uno K; Kataoka Y; Kapadia SR; Tuzcu EM; Nicholls SJ
Am J Cardiol; 2014 Nov; 114(10):1465-72. PubMed ID: 25282317
[TBL] [Abstract][Full Text] [Related]
14. Impact of statins on serial coronary calcification during atheroma progression and regression.
Puri R; Nicholls SJ; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nissen SE
J Am Coll Cardiol; 2015 Apr; 65(13):1273-1282. PubMed ID: 25835438
[TBL] [Abstract][Full Text] [Related]
15. A meta-analysis of randomized head-to-head trials for effects of rosuvastatin versus atorvastatin on apolipoprotein profiles.
Takagi H; Umemoto T;
Am J Cardiol; 2014 Jan; 113(2):292-301. PubMed ID: 24230979
[TBL] [Abstract][Full Text] [Related]
16. Comparison of arterial remodeling and changes in plaque composition between patients with progression versus regression of coronary atherosclerosis during statin therapy (from the TRUTH study).
Nozue T; Yamamoto S; Tohyama S; Fukui K; Umezawa S; Onishi Y; Kunishima T; Sato A; Nozato T; Miyake S; Takeyama Y; Morino Y; Yamauchi T; Muramatsu T; Hibi K; Terashima M; Michishita I;
Am J Cardiol; 2012 May; 109(9):1247-53. PubMed ID: 22325089
[TBL] [Abstract][Full Text] [Related]
17. Meta-Analysis Comparing the Effect of Combined Omega-3 + Statin Therapy Versus Statin Therapy Alone on Coronary Artery Plaques.
Fan H; Zhou J; Yuan Z
Am J Cardiol; 2021 Jul; 151():15-24. PubMed ID: 34049675
[TBL] [Abstract][Full Text] [Related]
18. Impact of Dual Lipid-Lowering Strategy With Ezetimibe and Atorvastatin on Coronary Plaque Regression in Patients With Percutaneous Coronary Intervention: The Multicenter Randomized Controlled PRECISE-IVUS Trial.
Tsujita K; Sugiyama S; Sumida H; Shimomura H; Yamashita T; Yamanaga K; Komura N; Sakamoto K; Oka H; Nakao K; Nakamura S; Ishihara M; Matsui K; Sakaino N; Nakamura N; Yamamoto N; Koide S; Matsumura T; Fujimoto K; Tsunoda R; Morikami Y; Matsuyama K; Oshima S; Kaikita K; Hokimoto S; Ogawa H;
J Am Coll Cardiol; 2015 Aug; 66(5):495-507. PubMed ID: 26227186
[TBL] [Abstract][Full Text] [Related]
19. C-reactive protein, but not low-density lipoprotein cholesterol levels, associate with coronary atheroma regression and cardiovascular events after maximally intensive statin therapy.
Puri R; Nissen SE; Libby P; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
Circulation; 2013 Nov; 128(22):2395-403. PubMed ID: 24043299
[TBL] [Abstract][Full Text] [Related]
20. Three-dimensional morphological response of lipid-rich coronary plaques to statin therapy: a serial optical coherence tomography study.
Wang Z; Cho YS; Soeda T; Minami Y; Xing L; Jia H; Aguirre A; Vergallo R; Lee H; Fujimoto JG; Yu B; Jang IK
Coron Artery Dis; 2016 Aug; 27(5):350-6. PubMed ID: 27105047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
